Reprogram Biosciences Closes $6M Seed Financing
· vcnewsdaily.com
SAN CARLOS, CA, Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, announced the close of its seed financing.
Reprogram Biosciences Closes $6M Seed Financing Back to Home
SAN CARLOS, CA, Reprogram Biosciences, a preclinical oncology biotechnology company developing mRN...